Skip to main content
Independent federal grant matching. Not affiliated with any government agency. Get free access and see which open grants fit your organization.
Closed on Jun 19, 2026

Increasing awareness and knowledge of Alpha-gal Syndrome in the United States

Centers for Disease Control - NCEZID · Opportunity number CDC-RFA-CK-26-0193

Details summarized from the official notice as of Jun 20, 2026. Always confirm eligibility, deadlines and requirements in the official notice before applying.

Independent platform. Not affiliated with or endorsed by any government agency. Data from public federal sources.

This opportunity is closed as of Jun 19, 2026. It is kept here for reference. See the related open opportunities below, or check the official listing in case the agency posts a new cycle.

Key facts

Opportunity numberCDC-RFA-CK-26-0193
AgencyCenters for Disease Control - NCEZID
Department of Health and Human Services
Assistance listing (ALN, formerly CFDA)93.084
PostedMay 19, 2026
DeadlineJun 19, 2026
Award ceiling$1,000,000
Award floor$25,000
Expected number of awards3
Estimated total program funding$10,000,000
Cost sharing or matching requiredNo
Funding typeCooperative agreement
CategoryHealth
Last updated hereJun 20, 2026

Summary from the notice

The purpose of this NOFO is to improved awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding. The NOFO strategies are to 1) SHARE - Formation of an association of AGS professionals to disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response. 2) EDUCATE - Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, outdoor workers, etc.). Create communications targeted at healthcare providers including educational resources and training. 3) TRACK - Conduct active or enhances public health surveillance for AGS. This strategy could involve patient populations or geographical locations with limited access to specialized healthcare provider care. Social Determinants of Health impacts could be considered as well. Please note that applicants must apply for strategy number 1 (SHARE) and that strategies 2 (EDUCATE) and 3 (TRACK) are optional.

Who can apply

The official notice lists these applicant types as eligible:

  • For-profit organizations other than small businesses
  • Small businesses
  • Nonprofits without 501(c)(3) status (other than colleges)
  • State governments
  • Private colleges and universities
  • Public and state colleges and universities
  • Other Native American tribal organizations
  • Special district governments
  • Independent school districts
  • Federally recognized tribal governments
  • Public and Indian housing authorities
  • Nonprofits with 501(c)(3) status (other than colleges)
  • City or township governments
  • Unrestricted (open to any type of entity, check the notice)
  • County governments

Eligibility details from the notice

Bona fide agents are eligible to apply. For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located at https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2

Registrations you will likely need

Most applications submitted through Grants.gov need the following. Registration can take several weeks, so start early. The notice lists the exact requirements.

Related open opportunities

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

National Institutes of Health · PAR-25-155

Deadline: Oct 19, 2026 (3 days left) Up to: $50,000 Health

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

National Institutes of Health · RFA-CA-27-021

Deadline: Oct 19, 2026 (3 days left) Up to: $600,000 Health